Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report A 2026 landscape of bioinspired suction cup gripper technology: octopus-inspired designs, self-sealing membranes, AI grasp planning, and key research institutions.
Article | Report A 2026 technology landscape of nanostructured HER catalysts: TMDs, single-atom catalysts, high-entropy alloys, and carbon scaffolds driving green hydrogen at industrial scale.
Article | Report Aldosterone synthase inhibitors, AVS alternatives, and cure approaches in the primary hyperaldosteronism pipeline — from CYP11B2 inhibitors to PET imaging.
Article | Report A 2026 technology landscape of magnetic particle chain actuators: patent signals, key clusters, geographic trends, and strategic IP implications for R&D teams.
Article | Report Fetal hemoglobin induction, luspatercept expansion, and gene editing in the beta-thalassemia drug pipeline — patent signals, clinical data, and strategic implications.
Article | Report Mapping the 2026 optical fiber displacement sensor landscape: four sensing clusters, key assignees, geographic trends, and five emerging directions from patent and literature analysis.
Article | Report Explore the AL amyloidosis drug pipeline: daratumumab combinations, birtamimab, CAEL-101, CAR-T, and emerging organ-protection strategies shaping rare disease R&D.
Article | Report A 2026 patent and literature landscape of electrochemical bromine recovery: membrane flow cells, battery recycling, flow batteries, and emerging IP signals.
Article | Report Fibril clearance antibodies, SAP depletion, and cardiac remodeling approaches in the ATTR cardiac amyloidosis drug pipeline — patent signals and clinical evidence.
Article | Report Explore the 2026 photonic QKD technology landscape: key protocols, distance records, chip-scale integration, and strategic IP implications from 20+ years of patent data.
Article | Report Photonic QKD has reached 658 km fiber range and 1 Gbit/s key rates. Explore the 2026 technology landscape: protocols, chip integration, and IP white spaces.
Article | Report Burosumab expansion, FGF23 pathway inhibitors, and phosphate metabolism approaches shaping the XLH drug pipeline. Evidence from patents and clinical trials.
Article | Report Explore the 2026 electrochemical levulinic acid technology landscape: key patents, ECH benchmarks, assignee gaps, and emerging paired electrolysis directions.
Article | Report Explore the MCI prevention drug pipeline: BDNF/TrkB signaling, synaptic plasticity, NMDA receptor modulators, and multi-modal approaches targeting pre-dementia cognitive decline.
Article | Report A 2026 patent landscape analysis of plasma ozone generation: DBD reactors, AI-controlled systems, plasma vortex, UV-photocatalytic hybrids, and key assignees across Japan, Korea, and Europe.